Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Soleno Therapeutics has recently filed with the U.S. Securities and Exchange Commission, officially announcing the withdrawal of its marketing authorization application for the drug Viokas in Europe.

Soleno Therapeutics has recently filed with the U.S. Securities and Exchange Commission, officially announcing the withdrawal of its marketing authorization application for the drug Viokas in Europe.

老虎证券老虎证券2026/04/07 11:33
Show original
This decision marks the temporary suspension of the commercialization process of this drug in the European market.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51

BNB fell below $690

金色财经•2026/11/04 02:37
BNB fell below $690